USP6NL
Basic information
Region (hg38): 10:11460510-11611666
Previous symbols: [ "USP6NL-IT1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP6NL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 53 | 56 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 53 | 3 | 0 |
Variants in USP6NL
This is a list of pathogenic ClinVar variants found in the USP6NL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-11462505-G-A | not specified | Uncertain significance (Apr 03, 2023) | ||
10-11462539-C-A | not specified | Uncertain significance (Oct 26, 2022) | ||
10-11462548-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
10-11462595-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
10-11462602-C-T | not specified | Uncertain significance (Nov 07, 2023) | ||
10-11462716-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
10-11462812-C-T | not specified | Uncertain significance (Jan 26, 2023) | ||
10-11462829-A-G | not specified | Uncertain significance (Aug 21, 2023) | ||
10-11462861-G-C | not specified | Uncertain significance (Jun 28, 2022) | ||
10-11462880-T-C | not specified | Uncertain significance (Oct 29, 2021) | ||
10-11462884-C-G | not specified | Uncertain significance (Jan 30, 2024) | ||
10-11462889-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
10-11462934-T-C | not specified | Uncertain significance (May 26, 2023) | ||
10-11463025-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
10-11463057-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
10-11463106-G-C | not specified | Uncertain significance (Jan 04, 2024) | ||
10-11463112-T-C | not specified | Uncertain significance (Jun 06, 2023) | ||
10-11463172-G-A | not specified | Uncertain significance (Feb 03, 2022) | ||
10-11463189-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
10-11463204-T-C | not specified | Uncertain significance (Jan 22, 2024) | ||
10-11463214-C-A | not specified | Uncertain significance (Jun 11, 2024) | ||
10-11463246-C-T | not specified | Likely benign (Nov 01, 2021) | ||
10-11463309-T-A | not specified | Uncertain significance (Feb 07, 2023) | ||
10-11463315-T-A | not specified | Uncertain significance (Dec 22, 2023) | ||
10-11463330-T-C | not specified | Uncertain significance (Oct 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USP6NL | protein_coding | protein_coding | ENST00000277575 | 14 | 157809 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.121 | 0.879 | 124583 | 0 | 59 | 124642 | 0.000237 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.146 | 468 | 459 | 1.02 | 0.0000272 | 5484 |
Missense in Polyphen | 93 | 123.42 | 0.75351 | 1492 | ||
Synonymous | -0.876 | 202 | 187 | 1.08 | 0.0000127 | 1637 |
Loss of Function | 4.43 | 10 | 40.3 | 0.248 | 0.00000246 | 494 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000856 | 0.000855 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000178 | 0.000177 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.000463 | 0.000458 |
Other | 0.000179 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a GTPase-activating protein for RAB5A and RAB43. Involved in receptor trafficking. In complex with EPS8 inhibits internalization of EGFR. Involved in retrograde transport from the endocytic pathway to the Golgi apparatus. Involved in the transport of Shiga toxin from early and recycling endosomes to the trans-Golgi network. Required for structural integrity of the Golgi complex. {ECO:0000269|PubMed:11099046, ECO:0000269|PubMed:17562788, ECO:0000269|PubMed:17684057}.;
- Pathway
- EGF-EGFR Signaling Pathway;Vesicle-mediated transport;Membrane Trafficking;EGFR1;ErbB1 downstream signaling;PDGFR-beta signaling pathway;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.152
Intolerance Scores
- loftool
- 0.878
- rvis_EVS
- -0.75
- rvis_percentile_EVS
- 13.67
Haploinsufficiency Scores
- pHI
- 0.254
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.752
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Usp6nl
- Phenotype
Gene ontology
- Biological process
- intracellular protein transport;Golgi organization;virion assembly;retrograde transport, plasma membrane to Golgi;positive regulation of GTPase activity;plasma membrane to endosome transport;activation of GTPase activity;regulation of cilium assembly;regulation of Golgi organization
- Cellular component
- cytosol;plasma membrane;cytoplasmic vesicle;trans-Golgi network membrane
- Molecular function
- GTPase activator activity;Rab GTPase binding